Log in

ASX:FPHFisher & Paykel Healthcare Stock Price, Forecast & News

+0.74 (+2.64 %)
(As of 05/13/2020)
Today's Range
Now: A$28.74
50-Day Range
MA: A$27.41
52-Week Range
Now: A$28.74
Volume575,466 shs
Average Volume371,449 shs
Market Capitalization$16.51 billion
P/E Ratio117.31
Dividend Yield0.86%
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems worldwide. The company offers its products for use in respiratory, acute care, and surgery; and for the treatment of obstructive sleep apnea (OSA). It operates through four segments: New Zealand, North America, Europe, and Asia-Pacific. The company offers adult respiratory products, such as AIRVO 2 system, a humidifier with integrated flow source; Optiflow, a nasal high flow therapy; and noninvasive and invasive ventilation systems. It also provides infant respiratory products, including resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers surgical humidification systems; and homecare products comprising masks, CPAP devices, data management, humidifiers, and accessories. It markets and sells its products through its distribution subsidiaries, third party distributors, and original equipment manufacturers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.75 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices



Sales & Book Value

Annual Sales$707.99 million
Cash FlowA$0.29 per share
Book ValueA$0.93 per share



Market Cap$16.51 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive FPH News and Ratings via Email

Sign-up to receive the latest news and ratings for FPH and its competitors with MarketBeat's FREE daily newsletter.

Fisher & Paykel Healthcare (ASX:FPH) Frequently Asked Questions

How has Fisher & Paykel Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Fisher & Paykel Healthcare's stock was trading at A$24.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, FPH stock has increased by 19.2% and is now trading at A$28.74. View which stocks have been most impacted by Coronavirus.

How often does Fisher & Paykel Healthcare pay dividends? What is the dividend yield for Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare declared a interim dividend on Saturday, November 30th. Investors of record on Thursday, December 19th will be given a dividend of 0.114 per share on Thursday, December 19th. This represents a yield of 0.54%. The ex-dividend date is Friday, December 6th. This is a boost from Fisher & Paykel Healthcare's previous interim dividend of A$0.09. View Fisher & Paykel Healthcare's dividend history.

Has Fisher & Paykel Healthcare been receiving favorable news coverage?

News headlines about FPH stock have been trending negative on Monday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Fisher & Paykel Healthcare earned a daily sentiment score of -2.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutFisher & Paykel Healthcare.

Who are some of Fisher & Paykel Healthcare's key competitors?

What other stocks do shareholders of Fisher & Paykel Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fisher & Paykel Healthcare investors own include ServiceNow (NOW), Allena Pharmaceuticals (ALNA), Broadcom (AVGO), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Okta (OKTA), Taiwan Semiconductor Mfg. (TSM), Altimmune (ALT), Ampliphi Biosciences (APHB) and Avid Technology (AVID).

Who are Fisher & Paykel Healthcare's key executives?

Fisher & Paykel Healthcare's management team includes the following people:
  • Mr. Lewis G. Gradon, MD, CEO & Exec. Director (Age 58)
  • Ms. Andrea Blackie, Acting Chief Financial Officer
  • Dr. Andrew Somervell, VP of Products & Technology
  • Rachel Reynolds, Sr. Communications Mang.
  • Mr. Paul N. Shearer, Sr. VP of Sales & Marketing

What is Fisher & Paykel Healthcare's stock symbol?

Fisher & Paykel Healthcare trades on the ASX under the ticker symbol "FPH."

What is Fisher & Paykel Healthcare's stock price today?

One share of FPH stock can currently be purchased for approximately A$28.74.

How big of a company is Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare has a market capitalization of $16.51 billion and generates $707.99 million in revenue each year. Fisher & Paykel Healthcare employs 4,000 workers across the globe.

What is Fisher & Paykel Healthcare's official website?

The official website for Fisher & Paykel Healthcare is www.fphcare.com.

How can I contact Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare's mailing address is 15 Maurice Paykel Place, East Tamaki, AUCKLAND, 1061, New Zealand. The company can be reached via phone at +64-9-5740100.

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.